Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Vincent Lucente, MD, MBA

Advertisement

Articles by Vincent Lucente, MD, MBA

Novel devices for management of pelvic organ prolapse

ByVincent Lucente, MD, MBA,Jennifer Tymon, MD,Rafael Marquez, MD
November 2nd 2023

The pivot to patient safety.

Advertisement

Latest Updated Articles

  • Novel devices for management of pelvic organ prolapse
    Novel devices for management of pelvic organ prolapse

    November 2nd 2023



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

2

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

3

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

4

Amber Watters, MD, on emergency preparedness and building a version program

5

New tool translates pregnancy test research into individualized patient counseling resource

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us